Concertina Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.65 M
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2020
- Satisfied Charges ₹ 4.26 M
- Revenue Growth %
- Profit Growth -5603.50%
- Ebitda 96.00%
- Net Worth -0.56%
- Total Assets 0.15%
About Concertina Pharma
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239TG2005PTC045143
- Company No.
045143
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2005
- Date of AGM
30 Jul 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Concertina Pharma Private Limited offer?
Concertina Pharma Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Antidiabetic Medicine, Mineral Supplement, Carbonyl Iron Capsules, Calcium Carbonate Powder, Natural Calcium Carbonate.
Who are the key members and board of directors at Concertina Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyamala Achyutanna  | Managing Director | 19-Jan-2005 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkataramanjaneyapadma Achyutanna | Director | 28-Sep-2005 | Current |
| Achyutanna Chandana | Additional Director | 19-Jan-2011 | Current |
Financial Performance of Concertina Pharma.
Concertina Pharma Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 5603.5% decrease in profit. The company's net worth dipped by a decrease of 0.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Concertina Pharma?
In 2017, Concertina Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹4.26 M
Charges Breakdown by Lending Institutions
- State Bank Of Hyderabad : 0.43 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2005 | State Bank Of Hyderabad | ₹0.26 M | Satisfied |
| 17 Mar 2005 | State Bank Of Hyderabad | ₹4.00 M | Satisfied |
How Many Employees Work at Concertina Pharma?
Unlock and access historical data on people associated with Concertina Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Concertina Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Concertina Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.